Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Latin American regulatory reform boosts 20% growth in international trials

This article was originally published in Clinica

Executive Summary

The modernisation of clinical trial regulations in Latin America has contributed to a 20% rise in the number of international studies over the last four years, according to the US FDA's newsletter, Clinical Trials Advisor (October 16). Citing expert opinion, including from Wendy Buckland, vice-president of clinical development for Latin America at contract research organisation PPD, it reports that there are currently 323 trials (medtech and pharma) under way in Brazil, 292 in Mexico and 107 in Colombia.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT041098

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel